Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Viking Therapeutics Inc shares valued at $1,195,736 were sold by SINGLETON J MATTHEW on Aug 14 ’24. At $57.53 per share, SINGLETON J MATTHEW sold 20,786 shares. The insider’s holdings dropped to 9,500 shares worth approximately $0.54 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, SINGLETON J MATTHEW purchased 20,786 shares, netting a total of over 1,195,735 in proceeds.
Before that, ZANTE GREG had sold 16,136 shares from its account. In a trade valued at $922,212, the Chief Financial Officer traded Viking Therapeutics Inc shares for $57.15 each. Upon closing the transaction, the insider’s holdings decreased to 16,136 shares, worth approximately $10.66 million.
As published in their initiating research note from Morgan Stanley on June 27, 2024, Viking Therapeutics Inc [VKTX] has been an Overweight and the price target has been revised to $105. Analysts at Raymond James upgraded the stock from ‘”an Outperform”‘ to ‘”a Strong buy”‘ outlook in a report released in mid May. As of March 26, 2024, Oppenheimer has reiterated its “an Outperform” rating for VKTX. Earlier on March 07, 2024, Jefferies initiated its rating. Their recommendation was “a Buy” for VKTX stock.
Analyzing VKTX Stock Performance
During the last five days, there has been a surge of approximately 2.21%. Over the course of the year, Viking Therapeutics Inc shares have jumped approximately 206.29%. Shares of the company reached a 52-week high of $99.41 on 02/28/24 and a 52-week low of $17.23 on 01/03/24. A 50-day SMA is recorded $54.26, while a 200-day SMA reached $46.37. Nevertheless, trading volume fell to 1.9 million shares from 1.84 million shares the previous day.
Support And Resistance Levels for Viking Therapeutics Inc (VKTX)
According to the 24-hour chart, there is a support level at 55.95, which, if violated, would cause prices to drop to 54.91. In the upper region, resistance lies at 58.70. The next price resistance is at 60.41. RSI (Relative Strength Index) is 52.05 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.32, which suggests the price will increase in the coming days. Percent R is at 54.21%, indicating low price movement. Stochastics%K at holding indicates that the stock is to be held.
